Investing.com - Clovis reported on Friday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Clovis announced earnings per share of $-0.390 on revenue of $30.66M. Analysts polled by Investing.com anticipated EPS of $-0.395 on revenue of $38.05M.
Clovis shares are down 90% from the beginning of the year, still down 93.55% from its 52 week high of $4.13 set on November 11, 2021.
Clovis shares lost 2.10% in intra-day trade following the report.
Clovis follows other major Healthcare sector earnings this month
Clovis's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar